Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
about
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycinHybrid antibacterials. DNA polymerase-topoisomerase inhibitorsDo we need an intravenous fluoroquinolone?Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group.Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens.Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice.Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.Stereoselective synthesis of β-hydroxy enamines, aminocyclopropanes, and 1,3-amino alcohols via asymmetric catalysis.Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.A review on composite liposomal technologies for specialized drug delivery.Penetration of ciprofloxacin and fleroxacin into biliary tract.Renal handling of fleroxacin in rabbits, dogs, and humans.Resistance pattern of ciprofloxacin against different pathogens.Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.Anaphylactic reactions to cinoxacinEvaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model.Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureusEnoxacin relieves symptoms of recurrent urinary infections more rapidly than cefuroxime axetil.Pharmacokinetics of single-dose oral ciprofloxacin in infants and small childrenIn vitro activity of sparfloxacin compared with those of five other quinolonesDistribution of ciprofloxacin in ascitic fluid following administration of a single oral dose of 750 milligrams.Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials.Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.Efficacy of ciprofloxacin in an experimental model of Escherichia coli chorioamnionitis in rabbits.Ciprofloxacin. Best use of this new broad-spectrum antibiotic.Medicinal potential of ciprofloxacin and its derivatives.Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.Phytochemical and Antimicrobial Studies of Methyl Angolensate and Luteolin-7-O-glucoside Isolated from Callus Cultures of Soymida febrifuga.Influence of renal failure on ciprofloxacin pharmacokinetics in rats.Two-way and three-way approaches to ultra high performance liquid chromatography-photodiode array dataset for the quantitative resolution of a two-component mixture containing ciprofloxacin and ornidazole.Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.Ciprofloxacin as ocular liposomal hydrogelInterplay of the Quality of Ciprofloxacin and Antibiotic Resistance in Developing Countries.Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients.Synthesis and Evaluation of Ciprofloxacin-Nitroxide Conjugates as Anti-Biofilm Agents.Therapy of multidrug resistant typhoid in 58 children.Multi-drug-resistant Salmonella typhi--a need for therapeutic reappraisal.
P2860
Q28341927-2895F307-3EA4-4FA5-9ABE-FC2B1FEF5A23Q33234000-4A5DEBC9-EC9F-441B-9F4C-3F35BBE61AE3Q33606570-753F4611-B3E4-448A-900A-F5BD9116D5D9Q33696010-6AB7792B-F5C7-415A-874C-6B004382D4A4Q33720333-16C4BECF-552F-4612-8D59-47FC3DDCA449Q33744795-88F8F947-8A78-4AB5-872F-83B1235E3DF0Q33753240-C4F86C9B-4ABE-415B-AFB8-A31FE4752CB3Q34347059-28603BED-C519-4B9A-9160-91644C747A1BQ34458109-D229514A-ED4A-449F-A596-183CB69DA5A0Q34708209-0CB80619-E6A2-4184-9433-4AC8E097365AQ34730109-823C0D59-3465-4748-A4F4-11C03F64CC14Q35123362-A84277EA-2480-4011-9A14-5E9D92AE6D86Q35245673-1BB15094-FEE4-49E7-9992-8D85CE288EABQ35323705-23E09C96-3D81-4979-8F9D-1B671D676D14Q35353352-B80BD3C8-2891-46B6-A2B8-E470A7DC55C9Q35353461-2C243AEC-7D6C-405B-B1A8-6F19C2D6E576Q35706079-1351E998-263D-4E70-9C71-B1120C893D98Q35808500-2C510F13-71BE-4B00-AE6A-BE6A922E2F87Q35816058-BA974D0A-E208-479B-8BBB-A6D23C9F5EF5Q35817427-78CC6681-31DC-4552-9644-29941E87DB4DQ35836411-76BACFA4-B1E0-47FD-8A6B-F8EF488E5026Q35867076-16500490-0C68-490E-8785-20B7DCD76DF9Q35867393-C74FBDEF-EE78-4A71-B83A-7EF6529CB6EAQ35893937-80CA9721-012D-4516-B315-8C5437BF193FQ35921444-2DCE0E32-FEF8-41EB-B97C-93396C9B9D8DQ36757441-CE5D0CB5-6257-4783-9DF1-685D6A888B70Q37144908-7318B7CD-215C-4F12-B4C2-1526E9B551F3Q37926332-D2813EDC-087E-4337-9BBB-6AB0B7073A1CQ38068970-96F438A7-109D-42E7-92C0-2B36DE1E99B6Q39470224-4DADA7FF-376C-4035-8210-C03942E621BBQ39525855-5184B9C3-8DE2-4AD4-A727-96C78CBCC94DQ39556635-5D4CD224-BDAB-4455-B142-006C5D96521BQ39585784-E829D81C-198A-4D13-9CED-B2D75486D2CBQ39817138-C5F475A3-B821-4B32-A8E3-3315CABF0BDEQ39923976-0346FD87-F30F-4DF3-BFF7-3EF593E72F33Q40067159-E387C8E1-20B6-4D82-8DCF-884D06D32459Q40324048-443720DD-FBA9-49BF-9587-F86CC92F2F25Q40632086-CBDFCB57-0A6C-4591-96B8-938376187ACDQ40738808-1CFBC635-1A99-419D-B513-CDE6D9B3F9E1Q40740514-FA8B4398-8913-4A83-8F1B-26D44DCE4A90
P2860
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Ciprofloxacin. A review of its ...... roperties and therapeutic use.
@en
Ciprofloxacin. A review of its ...... roperties and therapeutic use.
@nl
type
label
Ciprofloxacin. A review of its ...... roperties and therapeutic use.
@en
Ciprofloxacin. A review of its ...... roperties and therapeutic use.
@nl
prefLabel
Ciprofloxacin. A review of its ...... roperties and therapeutic use.
@en
Ciprofloxacin. A review of its ...... roperties and therapeutic use.
@nl
P2093
P1433
P1476
Ciprofloxacin. A review of its ...... roperties and therapeutic use.
@en
P2093
D M Campoli-Richards
P Benfield
P304
P356
10.2165/00003495-198835040-00003
P577
1988-04-01T00:00:00Z
P6179
1011519943